In the final analysis group from the validation cohort (Supplementary Figure S2, Table 3), the quantity of intact provirus was higher in the TB group compared with the no-TB group (median 102; IQR, 0-737 vs 0; IQR, 0-24.5) intact provirus per million CD4+ T cells, respectively P=0.03, Figure 3A). The gene discussed is CD4; the disease is tuberculosis.